| Product Code: ETC5359034 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
Malta Buprenorphine market currently, in 2023, has witnessed an HHI of 9991, Which has decreased slightly as compared to the HHI of 10000 in 2017. The market is moving towards Highly concentrated. Herfindahl index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means fewer numbers of players or countries exporting in the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Buprenorphine Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Buprenorphine Market - Industry Life Cycle |
3.4 Malta Buprenorphine Market - Porter's Five Forces |
3.5 Malta Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Malta Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Malta Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Malta Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of buprenorphine therapy for opioid addiction treatment |
4.2.2 Growing prevalence of opioid addiction and the need for effective treatment options |
4.2.3 Government initiatives and policies promoting the use of buprenorphine in Malta |
4.3 Market Restraints |
4.3.1 High costs associated with buprenorphine treatment may limit access for some patients |
4.3.2 Stigma and misconceptions surrounding opioid addiction and its treatment with buprenorphine |
4.3.3 Regulatory challenges and restrictions affecting the availability and distribution of buprenorphine in Malta |
5 Malta Buprenorphine Market Trends |
6 Malta Buprenorphine Market Segmentations |
6.1 Malta Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Malta Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 Malta Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Malta Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Malta Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Malta Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Malta Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Malta Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Malta Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Malta Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Malta Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Malta Buprenorphine Market Import-Export Trade Statistics |
7.1 Malta Buprenorphine Market Export to Major Countries |
7.2 Malta Buprenorphine Market Imports from Major Countries |
8 Malta Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare providers trained in buprenorphine therapy |
8.2 Patient retention rates in buprenorphine treatment programs |
8.3 Number of public awareness campaigns conducted on opioid addiction and buprenorphine therapy |
9 Malta Buprenorphine Market - Opportunity Assessment |
9.1 Malta Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Malta Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Malta Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Malta Buprenorphine Market - Competitive Landscape |
10.1 Malta Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Malta Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |